Ovid Therapeutics Inc.

OVID | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.71

+$0.02 (+0.74%)

At close: Sep 21, 2026, 4:00 PM ET

$2.72

+$0.01 (+0.42%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.74%

(1D)

Rating

Updated: Aug 11, 2026

47.5

Fundamentals Average

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $505.79M

1D Range

2.65 2.76

52W Range

1.18 3.11

Valuation (TTM)

PE -7.53

PB 2.41

EV/EBITDA -11.21

Valuation (NTM)

Forward PE N/A

Forward PEG -0.57

Price Target $6.50

Cash Flow

FCF Yield -10.8%

SBC Adj. FCF Yield -11.3%

SBC Impact -4.8%

Margins

Gross Margin 100.0%

Operating Margin -3686.7%

FCF Margin -3460.1%

Growth (CAGR)

Revenue 3Y | 5Y 99.8% | -62.8%

Dil EPS 3Y | 5Y 7.9% | 23.4%

FCF 3Y | 5Y -1.8% | 2.3%

Returns

ROA -14.9%

ROE -23.6%

ROIC -26.1%

Financial Health

Net Cash

$117.22M

Current Ratio 12.39

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Ovid Therapeutics Inc. is a biopharmaceutical firm dedicated to creating significant treatments for individuals and families impacted by neurological disorders across the United States. The company's ...

Sector Healthcare

Industry Biotechnology

Employees 23

IPO Date May 4, 2017

Website www.ovidrx.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 11, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$6.50

Upside

+139.85%

Buy (4)

Hold (0)

Sell (0)

Analyst Details ➞